Cancer Research AACR Conference on Molecular Diagnostics - 2008  Joint Metastasis Research Society-AACR Conference on Metastasis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 30, 1473-1480, May 1, 1970]
© 1970 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maher, V. M.
Right arrow Articles by Summers, W. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maher, V. M.
Right arrow Articles by Summers, W. C.

Mutations and Loss of Transforming Activity of Bacillus subtilis DNA after Reaction with Esters of Carcinogenic N-Hydroxy Aromatic Amides1

Sr. Veronica M. Maher2, James A. Miller3, Elizabeth C. Miller and William C. Summers

Radiobiology Laboratories, Yale University School of Medicine, New Haven, Connecticut 06510 [S. V. M. R., W. C. S.], and McArdle Laboratory for Cancer Research, University of Wisconsin Medical Center, Madison, Wisconsin 53706 [J. A. M., E. C. M.]

Reaction of the sulfuric acid ester of N-hydroxy-4-acetylaminobiphenyl and of the acetic acid esters of N-hydroxy-4-acetylaminobiphenyl, N-hydroxy-4-acetylaminostilbene, and N-hydroxy-2-acetylaminophenanthrene with transforming DNA of Bacillus subtilis in vitro caused both inactivation of transforming activity and the induction of mutations. The parent amides, amines, N-hydroxy amides, and N-hydroxy amines each yielded little or no inactivation or mutation of the transforming DNA under similar conditions. These data are consistent with and in extension of our previous studies on the inactivation and mutation of transforming DNA by esters of N-hydroxy-2-acetylaminofluorene.

The magnitude of the inactivating and mutagenic activity of the esters depended both on the nature of the esterified acid and of the aryl group. Sulfuric acid esters of N-hydroxy-2-acetylaminofluorene and N-hydroxy-4-acetylaminobiphenyl were each more active than the corresponding acetic acid esters. Under similar conditions, the acetic acid ester of N-hydroxy-2-acetylaminofluorene caused more inactivation and more mutations than did the acetic acid esters of the other 3 N-hydroxy amides. In all cases, there was an approximately linear relationship between the extent of inactivation (expressed as lethal hits) and the frequency of mutations; the slopes of these lines were similar for all the esters studied.

The synthesis of N-hydroxy-2-aminophenanthrene, a new compound, is described.

1 Supported at Yale University by Program-Project Grant CA 06519 and at the University of Wisconsin by Program-Project Grant CA-07175 of the National Cancer Institute, USPHS, and at the University of Wisconsin by a grant from The Jane Coffin Childs Memorial Fund for Medical Research.

2 Present address: Marygrove College, Detroit, Mich. 48221.

3 To whom requests for reprints should be sent, at the McArdle Laboratory for Cancer Research, University of Wisconsin Medical Center, Madison, Wis. 53706.

Received 11/11/69. Accepted 1/22/70.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1970 by the American Association for Cancer Research.